Detalles de la búsqueda
1.
PATIENT MANAGEMENT TACTICS AT DIFFERENT STAGES OF GASTROINTESTINAL STROMAL TUMORS (GIST).
Wiad Lek
; 76(3): 682-686, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37057801
2.
Peculiarities of breast cancer incidence rate in urban population and implementation of screening programs in health care system.
Wiad Lek
; 69(1 Pt 2): 61-3, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27164278
3.
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study.
Lancet Oncol
; 12(8): 795-805, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21782507
4.
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES).
Clin Colorectal Cancer
; 16(2): 103-114.e3, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28038865
5.
Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer.
Clin Cancer Res
; 21(24): 5469-79, 2015 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341920
6.
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
J Clin Oncol
; 28(31): 4706-13, 2010 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20921462
7.
Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
J Thorac Oncol
; 3(7): 728-34, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18594318
Resultados
1 -
7
de 7
1
Próxima >
>>